LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

LLY

750.76

-1.27%↓

NVO

124.54

-0.75%↓

UNH

438.96

-0.71%↓

JNJ

147.47

-0.91%↓

MRK

125.56

-0.63%↓

HomeStock ListBecton Dickinson and Co

Becton Dickinson and Co

Closed

Sector Healthcare

241.09 -0.16

Overview

Share price change

24h

Current

Min

239.05

Max

243.23

Key metrics

By Trading Economics

Income

174M

282M

Sales

-381M

4.7B

P/E

Sector Avg

47.614

23.904

EPS

2.68

Dividend yield

1.379

Profit margin

5.992

Employees

73,000

EBITDA

-589M

1.1B

Recommendations

By TipRanks

Rating Consensus

Buy

12 Months Forecast

+19.99 upside

Dividends

By Dow Jones

Dividend Yield

Sector avg

1.38%

7.76%

Next earnings

2 May 2024

Next Dividend date

28 Jun 2024

Next Ex Dividend date

6 Jun 2024

Market Stats

By TradingEconomics

Market Cap

823M

70B

Previous open

241.25

Previous close

241.09

News Sentiment

By Acuity

50%

50%

108 / 274 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Becton Dickinson and Co chart

Related News

1 Feb 2024, 12:04 UTC

Earnings

Becton Dickinson Lifts 2024 Outlook After Sales Rise in 1Q

9 Nov 2023, 12:00 UTC

Earnings

Becton Dickinson Revenue Rises on Growth Across Segments

3 Aug 2023, 11:05 UTC

Earnings

Becton Dickinson 3Q Profit, Revenue Rose

21 Jul 2023, 23:13 UTC

Hot Stocks

Stocks to Watch: AMC Entertainment, Becton Dickinson and Verrica Pharmaceuticals

21 Jul 2023, 21:19 UTC

Major Market Movers

Becton Dickinson Shares Rise 4.6% on FDA 510(k) Clearance

27 Mar 2024, 21:59 UTC

Acquisitions, Mergers, TakeOvers

3M's Healthcare Spinoff Stock Fell. This Is What It's Worth. -- Barrons.com

27 Mar 2024, 09:15 UTC

Acquisitions, Mergers, TakeOvers

3M's Healthcare Spinoff Stock Is Trading. This Is What It's Worth. -- Barrons.com

1 Feb 2024, 11:34 UTC

Earnings

Becton Dickinson Sees FY24 Currency-Neutral Rev Growth 4.75%-5.5% >BDX

1 Feb 2024, 11:33 UTC

Earnings

Becton Dickinson Sees FY24 Organic Rev Growth 5.5%-6.25% >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q Net $281M >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson Sees FY Adj EPS $12.82-Adj EPS $13.06 >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q EPS 96c >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q Adj EPS $2.68 >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q Cont Ops EPS 96c >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson 1Q Rev $4.7B >BDX

1 Feb 2024, 11:30 UTC

Earnings

Becton Dickinson Sees FY Rev $20.2B-$20.4B >BDX

9 Nov 2023, 21:06 UTC

Market Talk

US Stocks Snap Winning Streak -- Market Talk

9 Nov 2023, 12:46 UTC

Market Talk
Earnings

Becton, Dickinson Extends Dividend Royalty -- Market Talk

9 Nov 2023, 11:34 UTC

Earnings

Becton Dickinson Sees FY24 Currency-Neutral Revenue Growth 4.5%-5.5% >BDX

9 Nov 2023, 11:33 UTC

Earnings

Becton Dickinson Sees FY24 Organic Revenue Growth 5.25%-6.25% >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson Sees FY Adj EPS $12.70-Adj EPS $13.00 >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson 4Q Net $108M >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson 4Q EPS 37c >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson Sees FY Rev $20.1B-$20.3B >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson 4Q Cont Ops EPS 53c >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson 4Q Adj EPS $3.42 >BDX

9 Nov 2023, 11:30 UTC

Earnings

Becton Dickinson 4Q Rev $5.1B >BDX

3 Aug 2023, 10:32 UTC

Earnings

Becton Dickinson Backs FY23 View of Adj EPS $12.10-Adj EPS $12.32 >BDX

3 Aug 2023, 10:32 UTC

Earnings

Becton Dickinson Now Sees FY23 Base Organic Revenue Growth 5.5%-5.8% >BDX

3 Aug 2023, 10:31 UTC

Earnings

Becton Dickinson Now Sees FY23 Revenue About $19.3B; Had Seen $19.2B-$19.3B >BDX

Peer Comparison

Price change

Becton Dickinson and Co forecast

Price Target

By TipRanks

19.99% upside

12 Months Forecast

Average 288.71 USD  19.99%

High 315 USD

Low 260 USD

Based on 7 Wall Street analysts offering 12 month price targets for Becton Dickinson and Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

240.24 / 241.56 Support&Resistance

Short Team

Very Strong Bearish Evidence

Intermediate Term

Bullish Evidence

Long Term

Weak Bearish Evidence

Sentiment

By Acuity

108 / 274 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Becton Dickinson and Co

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.